UF and Other Research Universities Will Fuel AI. Here’s Why
Alina Zare Ph.D., director of UF Artificial Intelligence and Informatics Research Institute, highlights how UF is helping shape the future of AI—positioning research universities as drivers of the next wave of innovation.
Forecasting the Final Frontier: How Research Prepares U.S. for the Next Solar Storm
UF researchers are developing solutions to help shield the U.S. from the next major solar storm by forecasting and modeling solar energetic particles and their impact on spacecraft and space-based infrastructure.
Scientists Wipe Out Aggressive Brain Cancer Tumors by Targeting Cellular ‘Motors’
A potential treatment for glioblastoma developed by UF researchers makes the deadly brain cancer newly sensitive to both radiation and chemotherapy, while also blocking its ability to invade other tissue.
Research Snapshot: Genetic Score Shows Promise in Improving Leukemia Outcomes
UF researchers have found that a genetic score holds promise for improving treatment results in patients with acute myeloid leukemia (AML) who have traditionally had poor outcomes by allowing chemotherapy regimens to be personalized.
Researchers Lay Groundwork for At-Home Cervical Cancer Screening
UF researchers have led a study that brings us one step closer to developing a simple, at-home test to prevent cervical cancer or detect it early—an advancement with the potential to transform early-stage diagnosis and treatment.
From Classroom to Cosmos: Students Aim To Build Big Things in Space
UF engineers are exploring how to manufacture precision metal structures in orbit using laser technology, in partnership with DARPA and NASA’s Marshall Space Flight Center.
UF-Bred MicroPure Genomics Awarded Competitive NSF Grant
MicroPure Genomics Inc., a revolutionary sample prep technology company with deep University of Florida roots, has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for nearly $1.3 million to conduct research and development on redefining front-end sample preparation for genomic analysis in research and healthcare.
TuHURA Biosciences Initiates Its Phase 3 Accelerated Approval Trial of IFx-2.0 as an Adjunctive Therapy to Keytruda® (Pembrolizumab) in First Line Treatment for Advanced or Metastatic Merkel Cell Carcinoma
TuHURA Biosciences, formed by CohBar and Morphogenesis, a UF startup, has announced the initiation of its Phase 3 accelerated approval trial of IFx-2.0, TuHURA’s lead innate immune agonist, in patients with advanced or metastatic Merkel cell carcinoma (MCC).
UF Health Researchers Propose AI Model To Predict Mortality in Coronary Artery Disease Patients
UF researchers have led a study proposing an artificial intelligence model to predict long-term mortality in patients with coronary artery disease.
Enzymes As Nanoscale Machines: The Intersection of AI, Biochemistry, and Engineering
UF researchers are harnessing artificial intelligence to design nanoscale enzyme machines, pushing the boundaries of biochemistry and engineering with long-term potential for transformative biotech applications.